Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review
METHODS Pertinent cross-sectional studies having as a reference standard pathological
examinations of the explanted liver or resected segment (s), biopsies of focal lesion (s) …
examinations of the explanted liver or resected segment (s), biopsies of focal lesion (s) …
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review
R Tateishi, H Yoshida, Y Matsuyama, N Mine… - Hepatology …, 2008 - Springer
Background and aims The role of alphafetoprotein (AFP) in the diagnosis and surveillance
of hepatocellular carcinoma (HCC) is getting smaller owing to the advances in imaging …
of hepatocellular carcinoma (HCC) is getting smaller owing to the advances in imaging …
Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I
M Grompe, S Lindstedt, M Al-Dhalimy, NG Kennaway… - Nature …, 1995 - nature.com
Hereditary tyrosinaemia type I, a severe autosomal recessive metabolic disease, affects the
liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). Mice …
liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). Mice …
[PDF][PDF] On‐treatment alpha‐fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir
GLH Wong, HLY Chan, YK Tse, HY Chan, CH Tse… - …, 2014 - Wiley Online Library
Alpha‐fetoprotein (AFP) is the most widely used biomarker for hepatocellular carcinoma
(HCC) surveillance, which is criticized as neither sensitive nor specific in active hepatitis and …
(HCC) surveillance, which is criticized as neither sensitive nor specific in active hepatitis and …
Alpha‐foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B
R Aghoram, P Cai, JA Dickinson… - Cochrane Database …, 1996 - cochranelibrary.com
Background Chronic hepatitis B virus infection is a risk factor for development of
hepatocellular carcinoma. Alpha‐foetoprotein and liver ultrasonography are used to screen …
hepatocellular carcinoma. Alpha‐foetoprotein and liver ultrasonography are used to screen …
Serum α-fetoprotein levels in patients with chronic hepatitis C: relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB …
NS Goldstein, DE Blue, R Hankin… - American journal of …, 1999 - academic.oup.com
Patients with chronic viral hepatitis and cirrhosis often have elevated serum (X-fetoprotein
(AFP) values, the causes of which are unclear. We studied 81 patients with chronic hepatitis …
(AFP) values, the causes of which are unclear. We studied 81 patients with chronic hepatitis …
Прогнозирование выживаемости при циррозе печени различной этиологии
МИ Рачковский - Москва, 2009 - static.freereferats.ru
ОБЩАЯ ХАРАКТЕРИСТИКА РАБОТЫ ктуалыюсть проблемы. По данным ВОЗ, в 2004
году во всем мире хроничес іе заболевания печени были причиной 1,382 млн смертей …
году во всем мире хроничес іе заболевания печени были причиной 1,382 млн смертей …
Proteomic analysis of HBV-associated HCC: insights on mechanisms of disease onset and biomarker discovery
D Niu, H Feng, WN Chen - Journal of Proteomics, 2010 - Elsevier
The development of hepatocellular carcinoma (HCC) can be considered as an end-stage
outcome of chronic hepatitis B virus (HBV) infection. Early prognostic markers are needed to …
outcome of chronic hepatitis B virus (HBV) infection. Early prognostic markers are needed to …
Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐and C‐endemic area
YC Huang, CF Huang, KC Chang… - Journal of …, 2011 - Wiley Online Library
Abstract Background and Aim: The aim of the present study was to elucidate a reasonable
model and the efficacy of hepatocellular carcinoma (HCC) screening on an elderly …
model and the efficacy of hepatocellular carcinoma (HCC) screening on an elderly …
Proteomics-related biomarkers for HBV-associated hepatocellular carcinoma: current status and future prospects
H Feng, J Zhang, JYL Tan, L Sadrolodabaee… - Future …, 2012 - Taylor & Francis
HBV infection is the major cause of the development of hepatocellular carcinoma (HCC).
HCC is one of the most common malignancies in the world. The morbidity rate associated …
HCC is one of the most common malignancies in the world. The morbidity rate associated …